Eupraxia Pharmaceuticals Inc.
EPRX
$7.51
-$0.07-0.92%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.44% | 350.07% | -28.01% | -17.06% | 282.15% |
| Total Receivables | 381.92% | 3.94% | -43.56% | 4.19% | 116.15% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 67.81% | -21.46% | 220.76% | -17.46% | -1.41% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -6.89% | 300.35% | -20.19% | -16.93% | 248.20% |
|
|
|||||
| Total Current Assets | -6.89% | 300.35% | -20.19% | -16.93% | 248.20% |
| Net Property, Plant & Equipment | 15.91% | 23.73% | 25.95% | 28.62% | -6.92% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -34.12% | 25.45% | -2.99% | -0.74% | 339.13% |
| Total Assets | -6.71% | 291.38% | -19.28% | -16.34% | 237.12% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 48.59% | 45.11% | 21.53% | -30.18% | 32.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.15% | 116.81% | -33.52% | -26.56% | -8.76% |
| Total Finance Division Other Current Liabilities | 48.75% | -2.43% | -36.28% | 118.36% | -7.17% |
| Total Other Current Liabilities | 48.75% | -2.43% | -36.28% | 118.36% | -7.17% |
| Total Current Liabilities | 47.68% | 45.55% | 19.02% | -29.11% | 30.80% |
|
|
|||||
| Total Current Liabilities | 47.68% | 45.55% | 19.02% | -29.11% | 30.80% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.68% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.05% | 49.16% | 19.02% | -29.11% | 30.01% |
|
|
|||||
| Common Stock & APIC | 4.40% | 53.05% | 0.98% | 1.41% | 0.78% |
| Retained Earnings | -10.93% | -4.34% | -6.34% | -5.16% | -6.08% |
| Treasury Stock & Other | 37.98% | -18.25% | 32.38% | 0.92% | -48.87% |
| Total Common Equity | -10.32% | 737.39% | -195.03% | -282.48% | -82.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -6.20% | 0.00% | 0.00% | 0.00% | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -6.20% | 0.00% | 0.00% | 0.00% | -- |
|
|
|||||
| Total Common Equity | -10.32% | 737.39% | -195.03% | -282.48% | -82.15% |
| Total Preferred Equity | -6.20% | 0.00% | 0.00% | 0.00% | -- |
| Total Minority Interest | -0.63% | -0.51% | -0.43% | -0.30% | -1.52% |
| Total Equity | -9.04% | 321.61% | -22.40% | -15.09% | 299.09% |
|
|
|||||